| Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’study HJN Andreyev, AR Norman, D Cunningham, J Oates, BR Dix, ... British journal of cancer 85 (5), 692-696, 2001 | 1080 | 2001 |
| Therapeutic vaccines for cancer: an overview of clinical trials I Melero, G Gaudernack, W Gerritsen, C Huber, G Parmiani, S Scholl, ... Nature reviews Clinical oncology 11 (9), 509-524, 2014 | 833 | 2014 |
| Photochemical internalization: a novel technology for delivery of macromolecules into cytosol K Berg, P Kristian Selbo, L Prasmickaite, TE Tjelle, K Sandvig, J Moan, ... Cancer research 59 (6), 1180-1183, 1999 | 575 | 1999 |
| Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study SL Bernhardt, MK Gjertsen, S Trachsel, M Møller, JA Eriksen, M Meo, ... British journal of cancer 95 (11), 1474-1482, 2006 | 369 | 2006 |
| Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer PF Brunsvig, S Aamdal, MK Gjertsen, G Kvalheim, ... Cancer Immunology, Immunotherapy 55, 1553-1564, 2006 | 359 | 2006 |
| Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer I Sæterdal, J Bjørheim, K Lislerud, MK Gjertsen, IK Bukholm, OC Olsen, ... Proceedings of the National Academy of Sciences 98 (23), 13255-13260, 2001 | 318 | 2001 |
| HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation‐a fast and reliable technique F Vartdal, G Gaudernack, S Funderud, A Bratlie, T Lea, J Ugelstad, ... Tissue antigens 28 (5), 301-312, 1986 | 312 | 1986 |
| Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma EO Vik-Mo, M Nyakas, BV Mikkelsen, MC Moe, P Due-Tønnesen, ... Cancer Immunology, Immunotherapy 62, 1499-1509, 2013 | 293 | 2013 |
| In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen. G Kaplan, G Gaudernack The Journal of experimental medicine 156 (4), 1101-1114, 1982 | 271 | 1982 |
| Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA JA Kyte, L Mu, S Aamdal, G Kvalheim, S Dueland, M Hauser, ... Cancer gene therapy 13 (10), 905-918, 2006 | 249 | 2006 |
| CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble inhibitor. JE Brinchmann, G Gaudernack, F Vartdal Journal of immunology (Baltimore, Md.: 1950) 144 (8), 2961-2966, 1990 | 249 | 1990 |
| Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation MK Gjertsen, J Breivik, I Saeterdal, E Thorsby, G Gaudernack, A Bakka, ... The Lancet 346 (8987), 1399-1400, 1995 | 244 | 1995 |
| Different genetic pathways to proximal and distal colorectal cancer influenced by sex‐related factors J Breivik, RA Lothe, GI Meling, TO Rognum, AL Børresen‐Dale, ... International journal of cancer 74 (6), 664-669, 1997 | 238 | 1997 |
| Long‐term follow‐up of patients with resected pancreatic cancer following vaccination against mutant K‐ras S Wedén, M Klemp, IP Gladhaug, M Møller, JA Eriksen, G Gaudernack, ... International Journal of Cancer 128 (5), 1120-1128, 2011 | 209 | 2011 |
| Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial PF Brunsvig, JA Kyte, C Kersten, S Sundstrøm, M Møller, M Nyakas, ... Clinical Cancer Research 17 (21), 6847-6857, 2011 | 207 | 2011 |
| Sialomucin CD34 is the major L-selectin ligand in human tonsil high endothelial venules. KD Puri, EB Finger, G Gaudernack, TA Springer The Journal of cell biology 131 (1), 261-270, 1995 | 200 | 1995 |
| Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21‐ras (12VAL) peptide vaccination of a patient, recognize 12VAL‐dependent nested epitopes … MK Gjertsen, J Bjørheim, I Saeterdal, J Myklebust, G Gaudernack International journal of cancer 72 (5), 784-790, 1997 | 194 | 1997 |
| K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location J Breivik, GI Meling, A Spurkland, TO Rognum, G Gaudernack British journal of cancer 69 (2), 367-371, 1994 | 190 | 1994 |
| Immune escape of cancer cells with beta2‐microglobulin loss over the course of metastatic melanoma AB Del Campo, JA Kyte, J Carretero, S Zinchencko, R Méndez, ... International journal of cancer 134 (1), 102-113, 2014 | 187 | 2014 |
| mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT) S Sæbøe-Larssen, E Fossberg, G Gaudernack Journal of immunological methods 259 (1-2), 191-203, 2002 | 180 | 2002 |
Erik ThorsbyProfessor of Immunology, University of Oslo, NorwayE-mail megerősítve itt: medisin.uio.no
